By Isadore Hall Special to California Black Media Partners Last spring, the Food and Drug Administration (FDA) approved the first new Alzheimer’s disease therapy since 2003. For the six million-plus people living with the fatal disease in the United States, the availability of a medicine designed to treat the underlying cause of their ailment was ...